Amulet Pharmaceuticals

company

About

Amulet Pharmaceuticals discovers and develops novel therapeutics to address known liabilities of current therapies serving unmet markets.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$1.70M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Close

Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.70M
Amulet Pharmaceuticals has raised a total of $1.70M in funding over 2 rounds. Their latest funding was raised on Mar 5, 2007 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 5, 2007 Series A $1.70M 1 Wilmington Investor Network Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Amulet Pharmaceuticals is funded by 1 investors. Wilmington Investor Network are the most recent investors.
Investor Name Lead Investor Funding Round
Wilmington Investor Network Yes Series A